We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+10.31%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.83B
AUM Growth
+$365M
Cap. Flow
+$14.3M
Cap. Flow %
0.37%
Top 10 Hldgs %
46.82%
Holding
177
New
6
Increased
30
Reduced
82
Closed
1

Top Buys

Rank Stock Value
1
RUSHA icon
Rush Enterprises Class A
RUSHA
+$20M
2
LH icon
Labcorp
LH
+$18.1M
3
SCHW
Charles Schwab
SCHW
+$10.1M
4
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$9.96M
5
WAT icon
Waters Corp
WAT
+$3.78M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$15.9M
2
MSFT icon
Microsoft
MSFT
+$14.2M
3
WMS icon
Advanced Drainage Systems
WMS
+$7.62M
4
MA icon
Mastercard
MA
+$3.36M
5
MDXG icon
MiMedx Group
MDXG
+$3.01M

Sector Composition

Rank Sector Weight
1 Financials 38.94%
2 Technology 13.69%
3 Healthcare 13.2%
4 Communication Services 7.56%
5 Industrials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QCOM icon
26
Qualcomm
QCOM
$164B
$51.1M 1.34%
429,555
+310
+0.1% +$35.6K
FERG icon
27
Ferguson
FERG
$43.9B
$50.2M 1.31%
319,322
+10,853
+4% +$1.55M
OWL icon
28
Blue Owl Capital
OWL
$6.45B
$49.5M 1.29%
4,244,870
+253,475
+6% +$2.73M
MKL icon
29
Markel Group
MKL
$25.2B
$46.7M 1.22%
33,793
-1,337
-4% -$1.79M
JNJ icon
30
Johnson & Johnson
JNJ
$640B
$46.1M 1.2%
278,233
-1,997
-0.7% -$322K
MA icon
31
Mastercard
MA
$498B
$44.2M 1.16%
112,395
-8,958
-7% -$3.36M
UNP icon
32
Union Pacific
UNP
$174B
$36.9M 0.96%
180,241
-1,495
-0.8% -$297K
LOW icon
33
Lowe's Companies
LOW
$121B
$36.6M 0.96%
162,244
-2,898
-2% -$603K
WAB icon
34
Wabtec
WAB
$49.3B
$32.9M 0.86%
300,389
-16,273
-5% -$1.62M
WBD icon
35
Warner Bros
WBD
$64.3B
$29.3M 0.76%
2,333,950
+62,783
+3% +$815K
TEVA icon
36
Teva Pharmaceuticals
TEVA
$40.4B
$28.1M 0.74%
3,737,686
-1,957,972
-34% -$15.9M
AAPL icon
37
Apple
AAPL
$4.97T
$26.6M 0.7%
137,218
-1,085
-0.8% -$189K
RUSHA icon
38
Rush Enterprises Class A
RUSHA
$6.34B
$22.1M 0.58%
+545,486
New +$20M
BN icon
39
Brookfield
BN
$102B
$20.4M 0.53%
909,966
-75,702
-8% -$1.6M
GSAT icon
40
Globalstar
GSAT
$10.1B
$20.1M 0.53%
1,241,040
+10,893
+0.9% +$175K
DOV icon
41
Dover
DOV
$26.7B
$19.8M 0.52%
133,808
-2,737
-2% -$391K
HUBB icon
42
Hubbell
HUBB
$24.4B
$19M 0.5%
57,165
-307
-0.5% -$85K
WMT icon
43
Walmart Inc
WMT
$909B
$18.1M 0.47%
346,068
-6,825
-2% -$344K
WMB icon
44
Williams Companies
WMB
$85.8B
$16.7M 0.44%
511,275
-1,900
-0.4% -$57K
MRK icon
45
Merck
MRK
$322B
$15.8M 0.41%
136,942
-2,178
-2% -$247K
SYY icon
46
Sysco
SYY
$40.8B
$14.3M 0.37%
192,478
-2,516
-1% -$186K
WMS icon
47
Advanced Drainage Systems
WMS
$10.6B
$14.2M 0.37%
125,137
-80,720
-39% -$7.62M
ENB icon
48
Enbridge
ENB
$120B
$14M 0.37%
377,097
-3,560
-0.9% -$136K
PKE icon
49
Park Aerospace
PKE
$720M
$12.1M 0.32%
873,600
+27,783
+3% +$368K
DUK icon
50
Duke Energy
DUK
$101B
$11.8M 0.31%
131,060
-2,248
-2% -$212K
1
2
3 4 5

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q2 2023 Portfolio in Review

As of Q2 2023, Beck Mack & Oliver held 177 positions worth $3.83B, up 11% from $3.46B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4%. Beck Mack & Oliver opened 6 new positions and exited 1, leaving the 177-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 39% a quarter earlier, followed by Technology and Healthcare.

  • Beck Mack & Oliver's largest Q2 2023 buy was Rush Enterprises Class A: 545,486 shares worth $22.1M.
  • Beck Mack & Oliver added most to Labcorp in Q2 2023, an estimated $18.1M increase.
  • Beck Mack & Oliver's biggest Q2 2023 reduction was Teva Pharmaceuticals, cutting an estimated $15.9M.
  • Beck Mack & Oliver fully exited CAE Inc. Common Shares in Q2 2023, selling an estimated $224K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $3.83B portfolio in Q2 2023.
  • Beck Mack & Oliver opened 6 new positions and closed 1 in Q2 2023.
  • Beck Mack & Oliver's portfolio value rose 11% quarter-over-quarter to $3.83B.

Based on Beck Mack & Oliver's 13F filing for Q2 2023, filed 8 Aug 2023.